|Articles|August 27, 2019
Containing Cytotoxic Product during Transport
Author(s)Flow Sciences, Inc.
The purpose of this document is to serve as a case study where a containment device was designed to facilitate “interim containment”, or containment during the portion of a process where the product isn’t inside the enclosure.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
3
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
4
Drug Digest: Closing the Gap in Modern Process Control and Automation for Quality
5
